GR1003868B - Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications - Google Patents
Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applicationsInfo
- Publication number
- GR1003868B GR1003868B GR20010100053A GR2001100053A GR1003868B GR 1003868 B GR1003868 B GR 1003868B GR 20010100053 A GR20010100053 A GR 20010100053A GR 2001100053 A GR2001100053 A GR 2001100053A GR 1003868 B GR1003868 B GR 1003868B
- Authority
- GR
- Greece
- Prior art keywords
- antioxidant
- wound healing
- mastic
- evaluation
- pharmaceutical
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
he present invention refers to the use of a product deriving from the plant Pistacia lentiscus var. chia of the Anacardiaceae family as an antioxidant, as wound healing inductor and as cytostatic. The invention also refers to the utilisation of theproduct in the preparation of pharmaceutical concoctions. The pharmaceutical concoction dosage form may be selected from a group which includes, among others, tablets, cremes, ointments, solutions, suspensions, gels (aqueous gels), shampoos, epidermal and transdermal patches, as well as systems for its administration through the mucus membranes and systems for its administrations through the mucosa of the oral cavity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20010100053A GR1003868B (en) | 2001-02-06 | 2001-02-06 | Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20010100053A GR1003868B (en) | 2001-02-06 | 2001-02-06 | Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1003868B true GR1003868B (en) | 2002-04-19 |
Family
ID=10944633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20010100053A GR1003868B (en) | 2001-02-06 | 2001-02-06 | Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1003868B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003092712A1 (en) * | 2002-05-01 | 2003-11-13 | Lavipharm S.A. | Use of mastic and its components for the control of microbial infections |
EP1520585A1 (en) * | 2003-10-02 | 2005-04-06 | Data Medica Padova S.p.A. | Cancer treatment using natural plant products or essential oils or components from some pistacia species |
WO2010100650A2 (en) | 2009-03-04 | 2010-09-10 | Regenera Pharma Ltd. | Therapeutic uses of mastic gum fractions |
WO2012032523A2 (en) | 2010-09-07 | 2012-03-15 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
US8722105B2 (en) | 2009-03-04 | 2014-05-13 | Zadik Hazan | Compositions of polymeric myrcene |
EP3363448A1 (en) | 2017-02-15 | 2018-08-22 | Phytoitalia SRL | Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them |
WO2019170239A1 (en) | 2018-03-08 | 2019-09-12 | Phytoitalia Srl | Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2563109A1 (en) * | 1984-04-18 | 1985-10-25 | Truc Daniel | Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it |
CN1154852A (en) * | 1996-05-05 | 1997-07-23 | 于庆林 | Multi-purpose ointment for injury or wound |
US5725859A (en) * | 1994-05-03 | 1998-03-10 | Omer; Osama L.M. | Plant-based therapeutic agent with virustatic and antiviral effect |
WO2001021212A1 (en) * | 1999-09-22 | 2001-03-29 | Vassilios Papageorgiou | A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes |
-
2001
- 2001-02-06 GR GR20010100053A patent/GR1003868B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2563109A1 (en) * | 1984-04-18 | 1985-10-25 | Truc Daniel | Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it |
US5725859A (en) * | 1994-05-03 | 1998-03-10 | Omer; Osama L.M. | Plant-based therapeutic agent with virustatic and antiviral effect |
CN1154852A (en) * | 1996-05-05 | 1997-07-23 | 于庆林 | Multi-purpose ointment for injury or wound |
WO2001021212A1 (en) * | 1999-09-22 | 2001-03-29 | Vassilios Papageorgiou | A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes |
Non-Patent Citations (2)
Title |
---|
A.-H. Y. ABDEL-RAHMAN ET AL.: "MASTICH AS AN ANTIOXIDANT", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 52, no. 10, 1975, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 423, XP001024781, ISSN: 0003-021X * |
C.B. LESESNE: "THE POSTOPERATIVE USE OF WOUND ADHESIVES", JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, vol. 18, no. 11, November 1992 (1992-11-01), pages 990, XP001030919 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003092712A1 (en) * | 2002-05-01 | 2003-11-13 | Lavipharm S.A. | Use of mastic and its components for the control of microbial infections |
EP1520585A1 (en) * | 2003-10-02 | 2005-04-06 | Data Medica Padova S.p.A. | Cancer treatment using natural plant products or essential oils or components from some pistacia species |
US9655938B2 (en) | 2009-03-04 | 2017-05-23 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
CN106619700A (en) * | 2009-03-04 | 2017-05-10 | 瑞吉纳拉制药公司 | Therapeutic uses of mastic gum fractions |
US8722105B2 (en) | 2009-03-04 | 2014-05-13 | Zadik Hazan | Compositions of polymeric myrcene |
AU2010220057B2 (en) * | 2009-03-04 | 2015-04-02 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
AU2010220057C1 (en) * | 2009-03-04 | 2015-10-29 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
EP3578191A1 (en) | 2009-03-04 | 2019-12-11 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
US9364509B2 (en) | 2009-03-04 | 2016-06-14 | Regenera Pharma Ltd. | Therapeutic uses of mastic gum fractions |
US10806763B2 (en) | 2009-03-04 | 2020-10-20 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
WO2010100650A2 (en) | 2009-03-04 | 2010-09-10 | Regenera Pharma Ltd. | Therapeutic uses of mastic gum fractions |
US10307449B2 (en) | 2009-03-04 | 2019-06-04 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
US10251923B2 (en) | 2009-03-04 | 2019-04-09 | Regenera Pharma Ltd. | Therapeutic uses of mastic gum fractions |
US10159680B2 (en) | 2010-09-07 | 2018-12-25 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
WO2012032523A2 (en) | 2010-09-07 | 2012-03-15 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
US10561670B2 (en) | 2010-09-07 | 2020-02-18 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
US9271949B2 (en) | 2010-09-07 | 2016-03-01 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
EP3581177A2 (en) | 2010-09-07 | 2019-12-18 | Regenera Pharma Ltd. | Compositions comprising acidic extracts of mastic gum |
EP3363448A1 (en) | 2017-02-15 | 2018-08-22 | Phytoitalia SRL | Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them |
WO2019170239A1 (en) | 2018-03-08 | 2019-09-12 | Phytoitalia Srl | Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
HUP0302131A2 (en) | Pharmaceutical tramadol salts, pharmaceutical compositions containing them | |
AU2002235930A1 (en) | A process for the manufacture of a herbal composition comprising a matrine | |
RS77904A (en) | Oral administration form for difficulty soluble basic active ingredients which are applied orally | |
ES2187300A1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
HUP0402142A2 (en) | Composition of estrogen/gestagen combination, preparation and application thereof | |
GR1003868B (en) | Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications | |
WO2005076761A3 (en) | Composition for preenting a cold | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
MXPA05008843A (en) | Therapeutic system comprising amoxicillin and clavulanic acid. | |
TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
WO2006103119A3 (en) | Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics | |
WO2020190900A8 (en) | Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof | |
WO2012010938A3 (en) | Pharmaceutical composition of cefditoren pivoxil | |
WO2021054535A3 (en) | Stabilized efinaconazole-containing pharmaceutical composition comprising combination of chelating agent, antioxidant, and acid | |
EP1232748A4 (en) | Substituted nitrobenzene derivatives as medicines and other useful uses thereof | |
GR1004402B (en) | Evaluation of the antioxidant and cytoprotective ability of 5-(ethylidene-2oxo-tetrahydro-pyranyl-4) acetic acid and extracts from olives. olive oil, oil mill effluents and olive tree leaves and applications thereof | |
HU0200980D0 (en) | ||
GB0128071D0 (en) | Medicament | |
MX2021014830A (en) | CONJUGATES OF <i>Ï</i>-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS. | |
NO20005341D0 (en) | Treatment of depression and pharmaceutical compositions for this | |
WO2003103567A3 (en) | Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors | |
WO2003006668A3 (en) | Haptoglobin Derived Antioxidants | |
WO2011028416A3 (en) | Oral medication for the treatment of hemorrhoids and method of use |